Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Sees Significant Decline in Short Interest

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) saw a large decline in short interest in January. As of January 31st, there was short interest totalling 5,510,000 shares, a decline of 6.9% from the January 15th total of 5,920,000 shares. Based on an average daily trading volume, of 1,570,000 shares, the short-interest ratio is presently 3.5 days.

Acadia Healthcare Stock Down 0.5 %

Shares of Acadia Healthcare stock traded down $0.22 during trading on Thursday, hitting $40.67. 734,585 shares of the stock traded hands, compared to its average volume of 1,401,612. The company has a fifty day moving average price of $42.14 and a two-hundred day moving average price of $53.36. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77. The stock has a market cap of $3.78 billion, a P/E ratio of 13.33, a PEG ratio of 1.51 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on ACHC shares. Royal Bank of Canada reaffirmed an "outperform" rating and set a $64.00 target price on shares of Acadia Healthcare in a research note on Friday, January 10th. Barclays lowered their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research note on Friday, November 22nd. StockNews.com lowered shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. TD Cowen dropped their price target on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating on the stock in a report on Tuesday, January 7th. Finally, KeyCorp raised Acadia Healthcare from a "sector weight" rating to an "overweight" rating and set a $70.00 price objective for the company in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $70.22.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. State Street Corp boosted its holdings in Acadia Healthcare by 3.5% in the third quarter. State Street Corp now owns 2,819,911 shares of the company's stock worth $178,811,000 after purchasing an additional 95,613 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after acquiring an additional 454,044 shares during the last quarter. SG Americas Securities LLC raised its stake in shares of Acadia Healthcare by 713.3% in the 4th quarter. SG Americas Securities LLC now owns 110,866 shares of the company's stock valued at $4,396,000 after acquiring an additional 97,235 shares in the last quarter. LMR Partners LLP bought a new stake in Acadia Healthcare during the third quarter worth approximately $1,616,000. Finally, Beach Point Capital Management LP bought a new position in shares of Acadia Healthcare in the fourth quarter valued at approximately $14,097,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.